制造商:中外合资·陕西利威尔制药有限公司 一、高科技产品向威胁人类健康的“第三大杀手”宣战。 2000年,中华人民共和国卫生部批准了一种崭新的调节血糖功效成分——康立舒口服植物胰岛素胶囊上市,使我国成为世界上第一个获得口服植物胰岛素重大科技突破的国家。这是中国科学家在新世纪到来之际,向威胁人类健康的“第三大杀手”糖尿病发起的重大挑战,给亿万糖尿病患者带来了健康的福音。 Manufacturer: Sino-foreign joint ventures Shaanxi Li Weier Pharmaceutical Co., Ltd. A, high-tech products to threaten human health, “the third-largest killer” declaration of war. In 2000, the Ministry of Health of the People’s Republic of China approved a brand-new blood glucose regulating component - the introduction of Kang Lishu oral insulin capsule, making our country the first country in the world to achieve a major technological breakthrough in oral plant insulin. This is a great challenge Chinese scientists have brought to the “third-biggest killer” diabetes that threaten human health at the dawn of a new century, bringing healthy gospel to millions of people with diabetes.